You Can Knock-Out a Gene, But Can You Win the Match? Come and Find Out at the AmorChem l.p. KNOCK-OUT™ Event at Biocontact 2013 and You Could Qualify for an Amorchem Financing!

Published: Aug 02, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

August 2, 2013 -- Inspired by the popular television show “DRAGONS’ DEN”, AmorChem is hosting its first KNOCK-OUT Event at BioContact 2013, in Québec City. Researchers chosen to participate in the AmorChem KNOCK-OUT Event will fight it out in the ring against our panel of “Heavyweights” (seasoned biotech executives, all still standing, unbeaten after many rounds in the biotech arena), and you could be granted an AmorChem financing of up to $500,000.

If you are an academic life science researcher with an appetite to knock-out the competition, if you have innovative science with strong commercial potential, then you may be one of the participants chosen to duke it out in the AmorChem KNOCK-OUT Event.

Interested researchers must fill out the attached form describing their technology, its clinical applications, its relevance to human disease, as well as its commercial potential. As competition in the ring will be fierce, researchers are encouraged to seek the assistance of their technology transfer or commercialization office that can also prove useful in training for the final Event.

All application forms must be submitted no later than Friday, September 4th, 2013, at 8 pm at the following email address:

Participants chosen to bump fists in the final round will be notified no later than September 16th, 2013. They will then become Contenders in the Amorchem KNOCK-OUT Event and will be invited to a final “weigh-in” in the form of a conference call in order to assist them in their final preparations.

Contenders will then convene on October 2nd at the “AmorChem” session of BioContact 2013 in Québec City. Note that all Contenders must register for the conference in order to participate in the AmorChem KNOCK-OUT Event.

The Event will play out in front of a live audience. At the sound of the bell, each Contender will be given up to five minutes to make their case on their technology. Following their pitch, each Contender will duke it out, in the ring, with our “Heavyweights” over a seven minute Q&A “boxing match”. The Contenders will confront the “Heavyweights” with only wits and scientific agility in their corner. Just as boxers climb into the ring with only their gloves, our contenders will not be allowed visual support.

The champion of this first Québec edition of the AmorChem KNOCK-OUT Event may qualify for a financing of up to $500,000 from AmorChem, subject to completion of final pre-investment conditions including approval by the AmorChem Investment Committee. All Contenders will be invited to a dinner in Québec City with our “Heavyweights” following the Event.

Can you roll with the punches, and go 5 rounds in the ring with our seasoned biotech executives? If you think you can, act fast: spaces will be limited to a maximum of 7 participants and the deadline for application is September 4th, 2013!


AmorChem ( is a venture capital fund located in Montreal focused on investing in promising life science projects originating from Quebec-based universities and research centres. AmorChem’s innovative business model involves financing research-stage projects to enable them to reach pre-clinical proof-of-concept (POC) in a semi-virtual mode within 18-24 months. The fund seeks to generate returns through a two-pronged exit strategy: sell projects having reached POC to large biotechnology or pharmaceutical companies; or bundle them into new spin-out companies. Projects are managed by AmorChem using a combination of the resources found in the researcher’s lab, other academic labs and contract research organisations. In order to contribute efficiently to projects requiring small molecules, AmorChem established its own medicinal chemistry contract research organisation- NuChem Therapeutics Inc.



Help employers find you! Check out all the jobs and post your resume.

Back to news